Long-term Outcomes are Better with Long-term Dual Anti-Platelet Therapy after Drug-Eluting Stents: Insights from a Multi-centre Australian Study

Outcome Discharge (n= 2158) 30 days (n= 1739) 1 year (n = 1342) Death-overall 0.7% 0.7% 3.3% Unplanned re-admission to hospital – 3.6% 22.9% Recurrent angina – 2.5% 8.1% Aspirin 99.0% 97.7% 100% Clopidogrel 97.6% 95.3% 61.0% Statins 92.6% 95.0% 98.3% Conclusion: Australian practice and long-term outcomes after PCI are consistent with those reported in international registries. Compliance with guideline therapy is high. doi:10.1016/j.hlc.2011.05.335